134 results
Page 3 of 7
F-3
EX-5.1
pgzdn5v
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
EX-5.2
111aggfgo49 vlxa
31 Dec 20
Shelf registration (foreign)
4:37pm
F-3
k7toyy72d1i5w
31 Dec 20
Shelf registration (foreign)
4:37pm
6-K
EX-10.1
5gn1 wqelr36y
25 Sep 20
Current report (foreign)
4:33pm
424B5
tmxd6a
25 Sep 20
Prospectus supplement for primary offering
4:30pm
POS AM
9w9wzqfl5z1svsf
10 Aug 20
Prospectus update (post-effective amendment)
12:00am
424B3
391y9rok16di
2 Jul 20
Prospectus supplement
4:28pm
F-1
c9q 2mhg1zcjnzxj63w
26 Jun 20
Registration statement (foreign)
4:30pm
424B5
rlv dhnt8rh
3 Jun 20
Prospectus supplement for primary offering
8:33am
6-K
EX-99
u33uq2yh84 lppyf7syr
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
h7xd11
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
tz2dtx5oq cl9b37c
3 Jun 20
Current report (foreign)
8:30am
6-K
fszz1hn12xdik
3 Jun 20
Current report (foreign)
8:30am
6-K
EX-99
a1ejfxq3
1 Jun 20
BioLineRx Announces $4.39 Million Registered Direct Offering
8:05am
424B5
on4 bjyhh
28 May 20
Prospectus supplement for primary offering
12:00pm
6-K
EX-99
9sn27539s 8pp04wot
28 May 20
Current report (foreign)
11:56am
6-K
EX-10.3
7lo7ew3cc4 2dy
28 May 20
Current report (foreign)
11:56am
6-K
syw2riyw 8c
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
i5p9qmu 9a
28 May 20
Current report (foreign)
11:56am
6-K
EX-99
azg1 39ihm6g
26 May 20
BioLineRx Announces $9.0 Million Registered Direct Offering
8:45am